Amicus Therapeutics
FOLD
FOLD
206 hedge funds and large institutions have $3.36B invested in Amicus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 93 increasing their positions, 37 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1% less capital invested
Capital invested by funds: $3.41B → $3.36B (-$50.8M)
6.06% less ownership
Funds ownership: 112.02% → 105.96% (-6.1%)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
Holders
206
Holding in Top 10
9
Calls
$12.8M
Puts
$11.5M
Top Buyers
| 1 | +$40M | |
| 2 | +$39.6M | |
| 3 | +$37.8M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$36.8M |
| 5 |
Morgan Stanley
New York
|
+$31.7M |
Top Sellers
| 1 | -$103M | |
| 2 | -$39.1M | |
| 3 | -$20.5M | |
| 4 |
Millennium Management
New York
|
-$15.5M |
| 5 |
Jennison Associates
New York
|
-$9.5M |